A High-Salt Diet Can Trigger #Asthma!🧂 🎤Prof. Francesca Alessandrini, #HelmholtzMunich, explains that only women are affected and why the sex-specific finding drives #prevention and #PersonalizedMedicine. “Our new findings shed light onto the link of dietary salt and asthma incidence – a so far controversially discussed topic – and support the potential of dietary recommendations for the prevention of asthma or during its therapy.” Prof. Francesca Alessandrini, PI at the Institute of Allergy Research - Experimental Allergology, Helmholtz Munich 👉 Read her #interview: 🔗https://lnkd.in/dCUkyEks 💡 Personalized Medicine represents the future of healthcare. Therapies customized to individual patients hold the promise of exceptional effectiveness. 👉Learn more about Personalized Medicine at Helmholtz Munich: 🔗https://lnkd.in/dgwXk52X Michael Schloter Carsten B. Schmidt-Weber #Health #Allergy #salt #therapy #diet #research #AsthmaPrevention #microbiota #microbiom #lung
Helmholtz Munich
Forschungsdienstleistungen
Neuherberg, Bayern 25.079 Follower:innen
Wir entwickeln bahnbrechende Lösungen für eine gesündere Gesellschaft in einer sich schnell verändernden Welt.
Info
Unsere Welt verändert sich ständig, mit großen Auswirkungen auf unsere Gesundheit. Volkskrankheiten wie Diabetes, Allergien und Lungenerkrankungen nehmen weltweit rasant zu. Gleichzeitig entstehen neue Krankheiten, beispielsweise aufgrund des Klimawandels. Wir entwickeln Lösungen für eine gesündere Zukunft. Unsere Spitzenforschung bildet die Grundlage für medizinische Innovationen. Gemeinsam mit unseren Partnern beschleunigen wir den Transfer unserer Forschung, damit neue Ideen aus den Laboren noch schneller in der Gesellschaft ankommen. Helmholtz Munich zählt mehr als 2.500 Mitarbeitende und hat seinen Sitz in München/Neuherberg. Es ist Mitglied der Helmholtz-Gemeinschaft, mit mehr als 43.000 Mitarbeitenden und 18 Forschungszentren die größte Wissenschaftsorganisation in Deutschland. --- CEO und Wissenschaftlicher Geschäftsführer: Prof. Dr. med. Dr. h.c. Matthias H. Tschöp Administrativer Geschäftsführer: Dr. Michael Frieser
- Website
-
https://www.helmholtz-munich.de/en
Externer Link zu Helmholtz Munich
- Branche
- Forschungsdienstleistungen
- Größe
- 1.001–5.000 Beschäftigte
- Hauptsitz
- Neuherberg, Bayern
- Art
- Nonprofit
- Gegründet
- 1960
- Spezialgebiete
- Diabetes Research, Lung Research, Allergy Research, Personalized Medicine, Translational Research, Stem Cell Research, Epigenetics, Drug Discovery, Environmental Health und Enabling Technologies
Orte
Beschäftigte von Helmholtz Munich
Updates
-
Heute live! Unser CEO Prof. Matthias Tschöp spricht über "Die neue #Abnehmspritze – von der Entstehung bis zur Anwendung" an der Leopoldina. ▶️Livestream: https://t1p.de/qrhjf 📅10. Juli 🕒19:00 Uhr Mehr zum Thema im Interview: https://lnkd.in/dPw2TKXH Matthias H. Tschöp
-
Insights From the COVID-19 Pandemic: Change in Infection History and Islet Autoimmunity Incidence 🔬 💡 New research from the Global Plattform for the Prevention of Autoimmune Diabetes (#GPPAD) consortium, coordinated at #HelmholtzMunich, reveals that SARS-CoV-2 may have replaced other viruses as a risk factor for islet autoimmunity, crucial in #Type1Diabetes development. Despite fewer Coxsackie virus infections during early lockdowns, islet autoantibody rates didn't drop, suggesting a new viral influence. 👉 Read more: 🔗https://lnkd.in/d7Nx2iMs #WorldWithout1 #DiabetesResearch #COVID19 #T1D #diabetes #Coxsackie #lockdown #autoantibody #VirusInfection #diabetes #virus
-
🌟 Join us for the 1st Helmholtz Health Summit "The Future of Medicine" in Berlin on October 8th, 2024! 🌟 Dive into groundbreaking research, transformative ideas, and cutting-edge discussions at the forefront of health innovation. Meet leading experts, pioneers, and innovators from science, politics, biotech, and pharma. 🚀 📅 Date: October 8, 2024 🕒 Time: 12 PM - 10 PM 📍 Location: Berlin Don't miss this opportunity to shape the future of healthcare! Register now! https://lnkd.in/dXDt_URe Matthias H. Tschöp Helmholtz-Zentrum für Infektionsforschung, Helmholtz-Zentrum Hereon Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), DKFZ Deutsches Krebsforschungszentrum, Max Delbrück Center, Helmholtz-Gemeinschaft
-
Unlocking the Genetic Code of Diabetes!🧬 Our scientists at #HelmholtzMunich, in collaboration with an international team, have uncovered over 600 genetic markers linked to type 2 diabetes. This groundbreaking study reveals how these genes influence diabetes and its complications, paving the way for better treatments and personalized care. Dive into the future of diabetes research with us! 👉 https://lnkd.in/dDkTh2Ab #PersonalizedMedicine #Diabetes #Type2 #Genetics #Health Eleftheria Zeggini
-
Key Mechanisms Identified for Neuron #Regeneration 🧠 Neurological disorders, such as #trauma, #stroke, #epilepsy, and various #NeurodegenerativeDiseases, often lead to the permanent loss of #neurons, causing significant impairments in #brain function. Current treatment options are limited, primarily due to the challenge of replacing lost neurons. 👩🔬 Prof. Magdalena Götz and Boyan Bonev, with their teams, now reveal how #GlialCells are reprogrammed into #neurons via epigenetic modifications. 🧬 “The protein Ying Yang 1 is crucial for achieving the conversion from astrocytes to neurons. These findings are important to understand and improve reprogramming of glial cells to neurons, and thus brings us closer to therapeutic solutions.” Prof. Magdalena Götz Learn more about the breakthrough findings: 👉 https://lnkd.in/d9hVurgP Helmholtz Pioneer Campus @ Helmholtz Munich Munich Cluster for Systems Neurology (SyNergy) Ludwig-Maximilians-Universität München #HelmholtzMunich #Neuroscience #RegenerativeMedicine #Epigenetics #Research #Therapy #SyNergy #StemCell #NatureNeuroscience
-
Unlocking the Future of #PersonalizedMedicine🧬 🎤Interview with Prof. Michael Sattler about the impact of understanding molecular disease mechanisms to advance personalized therapies. “Understanding the three-dimensional structure of molecular targets allows to rationally design small molecule drugs. This is a bit like finding a specific key to open a door. Without having a picture of the lock, it is very difficult to manufacture a fitting key.” Prof. Michael Sattler, Director of the Molecular Targets and Therapeutics Center, #HelmholtzMunich 👉Learn more about the impact of RNA-splicing and protein designing for developing drugs tailored to individual patients: 🔗https://lnkd.in/d9awgkj5 👉Are you curious about more research of #PersonalizedMedicine at #HelmholtzMunich? Get fascinating insights on our topic page: 🔗https://lnkd.in/dgwXk52X #protein #Drug #RNA #splicing #AI #research #BiomedicalResearch
-
📢 #Jobalert ❗ Deine Expertise ist in unserem HR-Team gefragt! Werde Teil unseres Forschungszentrums als kompetente Ansprechperson in HR für unsere wissenschaftlichen Institute und administrativen Abteilungen. Unser Motto: „Gemeinsame Gestaltung für Spitzenforschung“. 🤓 Hier geht es zur #Jobchance bei #HelmholtzMunich als: 🔎 HR-Manager:in/ Personalmanager:in (m/w/d) 👉 https://lnkd.in/eHYhBYDj 🔎 Mitarbeiter:in Entgeltabrechnung (m/w/d) 👉https://lnkd.in/e2q8aXuN #HR #personal #buchhaltung
-
Highlights from the Transatlantic Big Science Conference 2024 in Berlin! Our CEO, Matthias H. Tschöp, led an insightful session on pandemic preparedness, addressing global disease threats, and strengthening international scientific resilience during crises. 🔬🌍 We were joined by esteemed experts from the World Health Organization, EMBL, Brookhaven National Laboratory, and CEPI (Coalition for Epidemic Preparedness Innovations) for this crucial discussion. The Transatlantic Big Science Conference aspires to create opportunities to renew and reinvigorate historic collaborations between scientists and organizations on both sides of the Atlantic and to empower transnational research communities to pursue transformational, sustainable solutions to global grand challenges. #GlobalHealth #PandemicPreparedness
-
Advancing Personalized Medicine through Molecular Insights🔬 Our scientists at #HelmholtzMunich are pioneering the transformation of personalized therapy development through understanding molecular disease mechanisms. Key advancements include targeted drug discovery, precision medicine using molecular structures, and AI-driven approaches, promising a bright future for personalized medicine. Explore the future of healthcare and the potential of personalized medicine with us! 👉 https://lnkd.in/dDkTh2Ab #PersonalizedMedicine #MolecularBiology #DrugDiscovery #AI Michael Sattler